Literature DB >> 27625361

GPI-80 expression highly purifies human cord blood-derived primitive CD34-negative hematopoietic stem cells.

Yoshikazu Matsuoka1, Keisuke Sumide1, Hiroshi Kawamura1,2, Ryusuke Nakatsuka1, Tatsuya Fujioka1, Yoshiaki Sonoda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27625361     DOI： 10.1182/blood-2016-03-704668

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  CD34-negative hematopoietic stem cells show distinct expression profiles of homing molecules that limit engraftment in mice and sheep.

Authors:  Tomoyuki Abe; Yoshikazu Matsuoka; Yoshikazu Nagao; Yoshiaki Sonoda; Yutaka Hanazono
Journal:  Int J Hematol       Date:  2017-07-07       Impact factor: 2.490

2.  The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units.

Authors:  Yoshikazu Matsuoka; Fumiaki Nakamura; Kazuo Hatanaka; Tatsuya Fujioka; Satoshi Otani; Takafumi Kimura; Yoshihiro Fujimura; Hiroaki Asano; Yoshiaki Sonoda
Journal:  Int J Hematol       Date:  2018-07-25       Impact factor: 2.490

3.  CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells.

Authors:  Yoshikazu Matsuoka; Masaya Takahashi; Keisuke Sumide; Hiroshi Kawamura; Ryusuke Nakatsuka; Tatsuya Fujioka; Yoshiaki Sonoda
Journal:  Cell Transplant       Date:  2016-11-30       Impact factor: 4.064

4.  A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells.

Authors:  Keisuke Sumide; Yoshikazu Matsuoka; Hiroshi Kawamura; Ryusuke Nakatsuka; Tatsuya Fujioka; Hiroaki Asano; Yoshihiro Takihara; Yoshiaki Sonoda
Journal:  Nat Commun       Date:  2018-06-06       Impact factor: 14.919

5.  Implications of hematopoietic stem cells heterogeneity for gene therapies.

Authors:  Jeremy Epah; Richard Schäfer
Journal:  Gene Ther       Date:  2021-02-15       Impact factor: 5.250

6.  GPI-80 Augments NF-κB Activation in Tumor Cells.

Authors:  Yuji Takeda; Yuta Kurota; Tomoyuki Kato; Hiromi Ito; Akemi Araki; Hidetoshi Nara; Shinichi Saitoh; Nobuyuki Tanaka; Norihiko Tsuchiya; Hironobu Asao
Journal:  Int J Mol Sci       Date:  2021-11-06       Impact factor: 5.923

7.  The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.

Authors:  Beat Bornhauser; Gunnar Cario; Anna Rinaldi; Thomas Risch; Virginia Rodriguez Martinez; Moritz Schütte; Hans-Jörg Warnatz; Nastassja Scheidegger; Paulina Mirkowska; Martina Temperli; Claudia Möller; Angela Schumich; Michael Dworzak; Andishe Attarbaschi; Monika Brüggemann; Mathias Ritgen; Ester Mejstrikova; Andreas Hofmann; Barbara Buldini; Pamela Scarparo; Giuseppe Basso; Oscar Maglia; Giuseppe Gaipa; Tessa-Lara Skoblyn; Geertruij Te Kronnie; Elena Vendramini; Renate Panzer-Grümayer; Malwine Jeanette Barz; Blerim Marovca; Mathias Hauri-Hohl; Felix Niggli; Cornelia Eckert; Martin Schrappe; Martin Stanulla; Martin Zimmermann; Bernd Wollscheid; Marie-Laure Yaspo; Jean-Pierre Bourquin
Journal:  Blood Adv       Date:  2020-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.